Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?

Julian Manuel Michael RogaschPatrick HundsdoerferChristian FurthFlorian WedelFrank HofheinzPaul-Christian KrügerHolger LodeWinfried BrennerAngelika EggertHolger AmthauerImke Schatka

Published in: European journal of nuclear medicine and molecular imaging (2017)

In this exploratory study, pretherapeutic image-derived and laboratory markers of tumoral metabolic activity in NB (ASP, MTV, urinary HVA/C) allowed the identification of children with a high and low risk of progression/relapse under current therapy.

Keyphrases

risk assessment
young adults
deep learning
heavy metals
stem cells
climate change